Trademark Overview
On Friday, March 7, 2025, a trademark application was filed for GLENMERE FARMS with the United States Patent and Trademark Office. The USPTO has given the GLENMERE FARMS trademark a serial number of 99073756. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Sunday, August 10, 2025. The GLENMERE FARMS trademark is filed in the Pharmaceutical Products and Education & Entertainment Services categories with the following description:
Education services, namely, providing online classes, programs, seminars, workshops, and training in the field of agriculture; Education services, namely, providing online classes, programs, seminars, workshops, and training in the field of cannabis, cannabis cultivation, cannabis manufacturing, cannabis products, and cannabis culture; Providing a website featuring non-downloadable videos in the field of agriculture, cannabis, cannabis cultivation, cannabis manufacturing, cannabis products, and cannabis culture; Providing information, news and commentary in the field of current events relating to cannabis, cannabis cultivation, cannabis manufacturing, cannabis products, and cannabis culture.
Medicinal herbal preparations, namely, medicinal cannabis, medicinal cannabis derivatives; Beverages for general health and well-being being a dietary supplement containing hemp and hemp derivatives; Beverages for general health and well-being being a dietary supplement containing cannabis derivatives; Pharmaceutical preparations and substances containing medicinal cannabis for general health and well-being; tetrahydrocannabinol oil for medical purposes; cannabidiol oil for medical purposes; all of the aforementioned goods not containing cannabis solely derived from hemp with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis and containing only trace amounts of naturally occurring CBD with no added CBD; Products for administering medical cannabis solely derived from hemp with a delta-9 THC concentration of no more than 0.3 percent on a dry weight basis, namely, buccal sprays, gel caps, and transdermal patches.
